Actively Recruiting
Evaluating Biofeedback vs Standard Therapy for Swallowing Problems After Stroke A Multicenter Randomized Controlled Trial in Adults
Led by IRCCS San Camillo, Venezia, Italy · Updated on 2026-03-27
100
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
I
IRCCS San Camillo, Venezia, Italy
Lead Sponsor
O
Ospedale Policlinico San Martino
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating whether biofeedback treatment is more effective than standard verbal feedback training in helping people recover from dysphagia after a stroke. This multicenter randomized controlled study will enroll 100 patients who have had a stroke and experience swallowing difficulties. The goal is to compare the recovery of swallowing function between those receiving biofeedback and those receiving conventional therapy without visual feedback. Participants will undergo 20 sessions over 4 weeks, attending five one-hour sessions each week. In the biofeedback group, sensors will be placed on the mylohyoid muscle to provide real-time visual feedback on muscle activity during swallowing exercises. The control group will perform the same swallowing maneuvers but will receive only verbal feedback from a speech therapist. Both groups will use effortful swallow techniques, timing and coordination tasks, and the Masako maneuver during training. Before starting treatment, and at two follow-up pointsafter 4 weeks of therapy and again two months laterpatients will have clinical and instrumental evaluations including fibroendoscopy and several swallowing function scales. Researchers will measure swallowing efficacy, penetrationaspiration, pharyngeal residues, and quality of life related to swallowing. Data will be analyzed statistically to assess treatment effects and safety throughout the study duration.
CONDITIONS
Brief Title
Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- First stroke injury
- Stroke onset more than six weeks prior
- Presence of dysphagia
- Good comprehension with Token Test score not below PT 53
- Good eyesight and hearing, or adequately corrected
You will not qualify if you...
- Conditions preventing good electromyographic signal recording such as skin infection, wound, or dermatitis in the submandibular area
- Severe illnesses affecting cooperation like fever, infections, metabolic problems, or serious cardiac insufficiency
- Serious dystonia or unintentional movements
- Disorders of consciousness
- Encephalopathy due to multiple infarcts
- Inability to sustain the experimental treatment
- Other neurological diseases, e.g., Parkinson disease
Research Team
S
Sara Nordio
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here